From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.
- Why Clinical Supply Teams Need To Understand CDISC
- The Hidden Cost Of Poor Data In Global Supply Chains
- The Hidden Cost Of Convenience: Single-Use Supply Chain Vulnerabilities And Clinical Trial Continuity
- The Fragility Of Efficiency: Why Global Clinical Supply Chains Fail In An Era Of Geopolitical Fragmentation
- Annex 22 Is Not A Brake On AI. It Is The Framework Clinical Supply Has Been Waiting For
- South Africa In Clinical Trial Supply: An Underrecognized Capability
- How Early Signals Prevent Risk In Clinical Trial Supply Chains
- The Fifth Model: Where It Works, Where It Doesn't, And The Economics Behind It
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Improving Site Efficiency With Automated Drug Resupply And Forecasting
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
GMP Clinical Storage Strategies for Today's Complex Trials
Temperature‑sensitive therapies need more than basic freezer space. Purpose‑built GMP storage protects product integrity, supports compliance, and adds flexibility as trial complexity grows.
-
Navigate Complex Ancillary Supply Sourcing Challenges
Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
How CDMOs Deliver Precision and Scale in Pharma Spray Drying
Spray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes
Explore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.
-
Rethinking RTSM Software: When Bigger Isn't Better
Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.
-
GMP Clinical Storage Solutions for Today's Complex Trials
How material traits, dosing approaches, and equipment design affect capsule‑filling accuracy and efficiency, giving teams insight to improve dose precision and support small‑scale manufacturing.
-
Using Tech Enabled Solutions To Boost Productivity And Sustainability
How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?
-
Effective Use Of IRT In Decentralized And Hybrid Clinical Trials
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.